

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of transforming growth factor beta2 production (GO:0032909) | 8.85627874 |
| 2 | angiotensin maturation (GO:0002003) | 8.52820400 |
| 3 | positive regulation of hair cycle (GO:0042635) | 8.03072323 |
| 4 | positive regulation of hair follicle development (GO:0051798) | 8.03072323 |
| 5 | regulation of cardioblast differentiation (GO:0051890) | 7.96646194 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 7.75561212 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 7.71530142 |
| 8 | regulation of guanylate cyclase activity (GO:0031282) | 7.13539889 |
| 9 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 7.05147776 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.03846401 |
| 11 | positive regulation of respiratory burst (GO:0060267) | 6.92464309 |
| 12 | gland morphogenesis (GO:0022612) | 6.72628086 |
| 13 | regulation of macrophage cytokine production (GO:0010935) | 6.43296855 |
| 14 | cardiac muscle cell proliferation (GO:0060038) | 6.26970435 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 6.24427070 |
| 16 | positive regulation of T cell apoptotic process (GO:0070234) | 6.15998212 |
| 17 | regulation of alkaline phosphatase activity (GO:0010692) | 6.09860894 |
| 18 | NADH metabolic process (GO:0006734) | 6.08633418 |
| 19 | drug catabolic process (GO:0042737) | 6.02580783 |
| 20 | exogenous drug catabolic process (GO:0042738) | 5.98932494 |
| 21 | lipoprotein transport (GO:0042953) | 5.97152937 |
| 22 | drug metabolic process (GO:0017144) | 5.90585041 |
| 23 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.80720177 |
| 24 | regulation of hair follicle development (GO:0051797) | 5.77000964 |
| 25 | urea metabolic process (GO:0019627) | 5.74902755 |
| 26 | cellular glucuronidation (GO:0052695) | 5.64089973 |
| 27 | regulation of bile acid biosynthetic process (GO:0070857) | 5.57451568 |
| 28 | cGMP biosynthetic process (GO:0006182) | 5.54047831 |
| 29 | positive regulation of odontogenesis (GO:0042482) | 5.52309408 |
| 30 | glucuronate metabolic process (GO:0019585) | 5.51819315 |
| 31 | uronic acid metabolic process (GO:0006063) | 5.51819315 |
| 32 | urea cycle (GO:0000050) | 5.48805669 |
| 33 | phospholipid efflux (GO:0033700) | 5.48008993 |
| 34 | glial cell migration (GO:0008347) | 5.45346531 |
| 35 | dopamine biosynthetic process (GO:0042416) | 5.36033269 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 5.28575958 |
| 37 | fructose metabolic process (GO:0006000) | 5.28200552 |
| 38 | plasma lipoprotein particle assembly (GO:0034377) | 5.24536923 |
| 39 | embryonic digestive tract development (GO:0048566) | 5.24107976 |
| 40 | striated muscle cell proliferation (GO:0014855) | 5.13888222 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 5.06454321 |
| 42 | vitamin A metabolic process (GO:0006776) | 4.88341593 |
| 43 | generation of neurons (GO:0048699) | 4.86272498 |
| 44 | protein-lipid complex assembly (GO:0065005) | 4.73113895 |
| 45 | glucocorticoid biosynthetic process (GO:0006704) | 4.68980434 |
| 46 | regulation of apoptotic cell clearance (GO:2000425) | 4.68955457 |
| 47 | positive regulation of epidermis development (GO:0045684) | 4.64263031 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64125756 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.62579696 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 4.62124732 |
| 51 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.59454185 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.59454185 |
| 53 | opsonization (GO:0008228) | 4.52990681 |
| 54 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.50253347 |
| 55 | bile acid metabolic process (GO:0008206) | 4.46789743 |
| 56 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.45912129 |
| 57 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 4.45479382 |
| 58 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.44222990 |
| 59 | diacylglycerol metabolic process (GO:0046339) | 4.41426645 |
| 60 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.41141504 |
| 61 | negative regulation of complement activation (GO:0045916) | 4.40539208 |
| 62 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 4.40380670 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.36802346 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 4.36802346 |
| 65 | macromolecular complex remodeling (GO:0034367) | 4.36802346 |
| 66 | ovulation from ovarian follicle (GO:0001542) | 4.35940009 |
| 67 | hormone catabolic process (GO:0042447) | 4.34641965 |
| 68 | citrulline biosynthetic process (GO:0019240) | 4.33697332 |
| 69 | omega-hydroxylase P450 pathway (GO:0097267) | 4.31955676 |
| 70 | positive regulation of macrophage differentiation (GO:0045651) | 4.26716415 |
| 71 | cardiac epithelial to mesenchymal transition (GO:0060317) | 4.26341161 |
| 72 | regulation of cGMP biosynthetic process (GO:0030826) | 4.26324047 |
| 73 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.24456350 |
| 74 | endocrine process (GO:0050886) | 4.24456350 |
| 75 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.24456350 |
| 76 | flavonoid metabolic process (GO:0009812) | 4.21501445 |
| 77 | muscle cell proliferation (GO:0033002) | 4.21024042 |
| 78 | somatic stem cell division (GO:0048103) | 4.17754861 |
| 79 | lipoprotein metabolic process (GO:0042157) | 4.17477758 |
| 80 | ethanol oxidation (GO:0006069) | 4.17044233 |
| 81 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 4.16812358 |
| 82 | positive regulation of cGMP metabolic process (GO:0030825) | 4.14389008 |
| 83 | arginine metabolic process (GO:0006525) | 4.04426395 |
| 84 | cholesterol efflux (GO:0033344) | 4.02415408 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 4.02268648 |
| 86 | negative regulation of sterol transport (GO:0032372) | 4.02268648 |
| 87 | reverse cholesterol transport (GO:0043691) | 4.00126080 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.94612752 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.89603915 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 3.88980818 |
| 91 | regulation of monocyte differentiation (GO:0045655) | 3.86467279 |
| 92 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.82751822 |
| 93 | regulation of systemic arterial blood pressure (GO:0003073) | 3.78510527 |
| 94 | regulation of cGMP metabolic process (GO:0030823) | 3.74527873 |
| 95 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.74463507 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.74327772 |
| 97 | collagen fibril organization (GO:0030199) | 3.71611724 |
| 98 | vitamin biosynthetic process (GO:0009110) | 3.69867441 |
| 99 | protein-lipid complex subunit organization (GO:0071825) | 3.69147415 |
| 100 | adhesion of symbiont to host cell (GO:0044650) | 3.68148724 |
| 101 | virion attachment to host cell (GO:0019062) | 3.68148724 |
| 102 | regulation of hair cycle (GO:0042634) | 3.67318144 |
| 103 | decidualization (GO:0046697) | 3.66961438 |
| 104 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.64962163 |
| 105 | phenylpropanoid metabolic process (GO:0009698) | 3.62667620 |
| 106 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.61918512 |
| 107 | regulation of cellular extravasation (GO:0002691) | 3.61093179 |
| 108 | membrane repolarization during action potential (GO:0086011) | 3.61065076 |
| 109 | heme transport (GO:0015886) | 3.54043108 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 3.52879536 |
| 111 | cGMP metabolic process (GO:0046068) | 3.52847710 |
| 112 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.50294360 |
| 113 | regulation of transforming growth factor beta production (GO:0071634) | 3.50274452 |
| 114 | drug transport (GO:0015893) | 3.50087313 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.48630006 |
| 116 | peptide hormone processing (GO:0016486) | 3.47115538 |
| 117 | homocysteine metabolic process (GO:0050667) | 3.44184911 |
| 118 | drug transmembrane transport (GO:0006855) | 3.44068167 |
| 119 | sterol homeostasis (GO:0055092) | 3.42432919 |
| 120 | regulation of complement activation (GO:0030449) | 3.41694598 |
| 121 | cell aggregation (GO:0098743) | 3.41475046 |
| 122 | cartilage condensation (GO:0001502) | 3.41475046 |
| 123 | fucose catabolic process (GO:0019317) | 3.41284349 |
| 124 | L-fucose metabolic process (GO:0042354) | 3.41284349 |
| 125 | L-fucose catabolic process (GO:0042355) | 3.41284349 |
| 126 | fat-soluble vitamin metabolic process (GO:0006775) | 3.41063067 |
| 127 | regulation of hypersensitivity (GO:0002883) | 3.38014739 |
| 128 | complement activation, alternative pathway (GO:0006957) | 3.37903451 |
| 129 | vitamin transport (GO:0051180) | 3.35659271 |
| 130 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.34128917 |
| 131 | digestion (GO:0007586) | 3.33374004 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.32400283 |
| 133 | vitamin catabolic process (GO:0009111) | 3.31603461 |
| 134 | fat-soluble vitamin catabolic process (GO:0042363) | 3.31603461 |
| 135 | peptide catabolic process (GO:0043171) | 3.31184495 |
| 136 | adhesion of symbiont to host (GO:0044406) | 3.28861880 |
| 137 | regulation of respiratory burst (GO:0060263) | 3.28256983 |
| 138 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.27609858 |
| 139 | interferon-gamma secretion (GO:0072643) | 3.26966302 |
| 140 | glycolipid catabolic process (GO:0019377) | 3.26019991 |
| 141 | ethanol metabolic process (GO:0006067) | 3.25544240 |
| 142 | L-ascorbic acid metabolic process (GO:0019852) | 3.24763453 |
| 143 | midgut development (GO:0007494) | 3.24685171 |
| 144 | glycosphingolipid catabolic process (GO:0046479) | 3.24206937 |
| 145 | response to hydroperoxide (GO:0033194) | 3.21506764 |
| 146 | negative regulation of fibrinolysis (GO:0051918) | 3.21322139 |
| 147 | oxidative demethylation (GO:0070989) | 3.20658660 |
| 148 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17690392 |
| 149 | glyoxylate metabolic process (GO:0046487) | 3.17060487 |
| 150 | complement activation, classical pathway (GO:0006958) | 3.16874621 |
| 151 | antibacterial humoral response (GO:0019731) | 3.16761511 |
| 152 | apoptotic cell clearance (GO:0043277) | 3.16207020 |
| 153 | regulation of fibrinolysis (GO:0051917) | 3.15606562 |
| 154 | regulation of protein activation cascade (GO:2000257) | 3.14042259 |
| 155 | proline metabolic process (GO:0006560) | 3.13739558 |
| 156 | vitamin transmembrane transport (GO:0035461) | 3.13080565 |
| 157 | drinking behavior (GO:0042756) | 3.12550625 |
| 158 | acylglycerol homeostasis (GO:0055090) | 3.12391054 |
| 159 | triglyceride homeostasis (GO:0070328) | 3.12391054 |
| 160 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11666637 |
| 161 | low-density lipoprotein particle remodeling (GO:0034374) | 3.11215131 |
| 162 | macrophage differentiation (GO:0030225) | 3.10893602 |
| 163 | regulation of cholesterol homeostasis (GO:2000188) | 3.09837220 |
| 164 | lung lobe morphogenesis (GO:0060463) | 3.09494986 |
| 165 | catechol-containing compound biosynthetic process (GO:0009713) | 3.06649107 |
| 166 | catecholamine biosynthetic process (GO:0042423) | 3.06649107 |
| 167 | basement membrane organization (GO:0071711) | 3.05450698 |
| 168 | blood vessel remodeling (GO:0001974) | 3.03679375 |
| 169 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 3.01773525 |
| 170 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.01750655 |
| 171 | renal system process involved in regulation of blood volume (GO:0001977) | 2.99383700 |
| 172 | glucocorticoid metabolic process (GO:0008211) | 2.97813977 |
| 173 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.92799452 |
| 174 | protein heterotrimerization (GO:0070208) | 2.90050535 |
| 175 | fucose metabolic process (GO:0006004) | 2.89894594 |
| 176 | hemidesmosome assembly (GO:0031581) | 2.88819457 |
| 177 | positive regulation of heart contraction (GO:0045823) | 2.87757801 |
| 178 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.84868277 |
| 179 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.84107680 |
| 180 | negative regulation of humoral immune response (GO:0002921) | 2.82736527 |
| 181 | positive regulation of macrophage activation (GO:0043032) | 2.80845904 |
| 182 | bile acid and bile salt transport (GO:0015721) | 2.79689353 |
| 183 | potassium ion import (GO:0010107) | 2.78866244 |
| 184 | potassium ion export (GO:0071435) | 2.72565693 |
| 185 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.70443177 |
| 186 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.69447022 |
| 187 | surfactant homeostasis (GO:0043129) | 2.68003517 |
| 188 | hydrogen peroxide catabolic process (GO:0042744) | 2.65104103 |
| 189 | intestinal absorption (GO:0050892) | 2.64639613 |
| 190 | excretion (GO:0007588) | 2.62931937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.92102699 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.78905757 |
| 3 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.45356813 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.30867090 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.09706434 |
| 6 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 3.00710071 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.97009549 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.85132911 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.80986094 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.74548417 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61184502 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41232426 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.27886470 |
| 14 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.27099384 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24940218 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.19849891 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.18151571 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.15795685 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.10687951 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99268790 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.99007426 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97357784 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94627350 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94363996 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.94212111 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.92742024 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.91863233 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90482189 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87277322 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.85661880 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84095233 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79883679 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78903653 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.77529962 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.76816301 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75207894 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74196799 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73013954 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72308384 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70680806 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70045185 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.68858958 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.64694053 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61754777 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58486842 |
| 46 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.53526115 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53169040 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52097085 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47825433 |
| 50 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44992028 |
| 51 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44992028 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.36892925 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36608599 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36600288 |
| 55 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.36026860 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35492142 |
| 57 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33995613 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32797026 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32548936 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32547472 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32032306 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31274649 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29778230 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29536583 |
| 65 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28508695 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27490427 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26179217 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26179217 |
| 69 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24986812 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24081201 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23955330 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22971717 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22965819 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21679668 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17978371 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17044313 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16938563 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16530301 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15781972 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15580827 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14802774 |
| 82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14802401 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13644891 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13597484 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13458604 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11226940 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11150132 |
| 88 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10262078 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09762111 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09577961 |
| 91 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08867988 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07839882 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06352342 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06177982 |
| 95 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.06140652 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05382796 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04863492 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04670531 |
| 99 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04402344 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04034269 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03992765 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03465937 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02606723 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02504810 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02452956 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02150268 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02115861 |
| 108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01653111 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01482301 |
| 110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01185569 |
| 111 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00770985 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00679004 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00200862 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98795291 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98699909 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98513292 |
| 117 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97584718 |
| 118 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97166299 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96288939 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94807657 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94707838 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94233984 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93468703 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93468703 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93307645 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.93262281 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93014366 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92977084 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92884151 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92741247 |
| 131 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92619430 |
| 132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91413364 |
| 133 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90467525 |
| 134 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89668066 |
| 135 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88891134 |
| 136 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87276944 |
| 137 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.84676949 |
| 138 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84593484 |
| 139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84522460 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82527736 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81317436 |
| 142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80914385 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.79395671 |
| 144 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.78825242 |
| 145 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.77080456 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76399079 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75764934 |
| 148 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75611487 |
| 149 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74501731 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74083688 |
| 151 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.73740975 |
| 152 | P300_27268052_Chip-Seq_Bcells_Human | 0.73163131 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.72833156 |
| 154 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72448730 |
| 155 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72284565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 6.20757149 |
| 2 | MP0002254_reproductive_system_inflammat | 5.79622961 |
| 3 | MP0005365_abnormal_bile_salt | 4.70987234 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.65530013 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.39085261 |
| 6 | MP0008004_abnormal_stomach_pH | 4.19431395 |
| 7 | MP0000681_abnormal_thyroid_gland | 3.57615078 |
| 8 | MP0003329_amyloid_beta_deposits | 3.38707383 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.37259235 |
| 10 | MP0000604_amyloidosis | 3.36555804 |
| 11 | MP0003183_abnormal_peptide_metabolism | 3.34964667 |
| 12 | MP0001664_abnormal_digestion | 2.61669260 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.60501146 |
| 14 | MP0001765_abnormal_ion_homeostasis | 2.43623925 |
| 15 | MP0003868_abnormal_feces_composition | 2.43471999 |
| 16 | MP0004147_increased_porphyrin_level | 2.40094342 |
| 17 | MP0003252_abnormal_bile_duct | 2.39524971 |
| 18 | MP0005332_abnormal_amino_acid | 2.30997175 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.25396535 |
| 20 | MP0005360_urolithiasis | 2.21833737 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.21065172 |
| 22 | MP0004272_abnormal_basement_membrane | 2.10453377 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.01041665 |
| 24 | MP0004883_abnormal_blood_vessel | 1.93395913 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.93236074 |
| 26 | MP0005275_abnormal_skin_tensile | 1.86295945 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.83094583 |
| 28 | MP0000462_abnormal_digestive_system | 1.80605978 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.80234510 |
| 30 | MP0001881_abnormal_mammary_gland | 1.77512468 |
| 31 | MP0001958_emphysema | 1.75707109 |
| 32 | MP0001764_abnormal_homeostasis | 1.72409061 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.69220428 |
| 34 | MP0005409_darkened_coat_color | 1.66800298 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.63455388 |
| 36 | MP0001177_atelectasis | 1.51405152 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.49984092 |
| 38 | MP0003195_calcinosis | 1.49927186 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.48517758 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.47631074 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.41220449 |
| 42 | MP0001727_abnormal_embryo_implantation | 1.40573247 |
| 43 | MP0003866_abnormal_defecation | 1.37391405 |
| 44 | MP0000609_abnormal_liver_physiology | 1.36028875 |
| 45 | MP0005164_abnormal_response_to | 1.33666115 |
| 46 | MP0003718_maternal_effect | 1.30794512 |
| 47 | MP0005670_abnormal_white_adipose | 1.30608338 |
| 48 | MP0003879_abnormal_hair_cell | 1.25692022 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.22378770 |
| 50 | MP0005451_abnormal_body_composition | 1.21589324 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.19913659 |
| 52 | MP0000490_abnormal_crypts_of | 1.19570906 |
| 53 | MP0000639_abnormal_adrenal_gland | 1.18012456 |
| 54 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15578621 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.14893860 |
| 56 | MP0002796_impaired_skin_barrier | 1.14375178 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.13578408 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.13179679 |
| 59 | MP0000249_abnormal_blood_vessel | 1.12618157 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.11305274 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.11047763 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07529830 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.07425337 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.02614827 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.99768536 |
| 66 | MP0001849_ear_inflammation | 0.98719108 |
| 67 | MP0005647_abnormal_sex_gland | 0.98243576 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 0.96396765 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.96304841 |
| 70 | MP0000627_abnormal_mammary_gland | 0.95689464 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.94850326 |
| 72 | MP0002822_catalepsy | 0.94241060 |
| 73 | MP0005448_abnormal_energy_balance | 0.93184998 |
| 74 | MP0001915_intracranial_hemorrhage | 0.92862198 |
| 75 | MP0000538_abnormal_urinary_bladder | 0.92449688 |
| 76 | MP0005535_abnormal_body_temperature | 0.91640279 |
| 77 | MP0002971_abnormal_brown_adipose | 0.91531860 |
| 78 | MP0002060_abnormal_skin_morphology | 0.90836947 |
| 79 | MP0001661_extended_life_span | 0.90783243 |
| 80 | MP0009697_abnormal_copulation | 0.90734280 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.89954251 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.89801827 |
| 83 | MP0004742_abnormal_vestibular_system | 0.89170167 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.87416316 |
| 85 | MP0001663_abnormal_digestive_system | 0.87099706 |
| 86 | MP0004858_abnormal_nervous_system | 0.86060544 |
| 87 | MP0003385_abnormal_body_wall | 0.85296186 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.85163911 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.83388725 |
| 90 | MP0005503_abnormal_tendon_morphology | 0.82316927 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.82216085 |
| 92 | MP0001756_abnormal_urination | 0.82170898 |
| 93 | MP0000751_myopathy | 0.82098418 |
| 94 | MP0008469_abnormal_protein_level | 0.82057582 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.81269610 |
| 96 | MP0001188_hyperpigmentation | 0.80289131 |
| 97 | MP0003448_altered_tumor_morphology | 0.79882340 |
| 98 | MP0003632_abnormal_nervous_system | 0.79681780 |
| 99 | MP0004270_analgesia | 0.79199418 |
| 100 | MP0001873_stomach_inflammation | 0.79105017 |
| 101 | MP0003045_fibrosis | 0.79022228 |
| 102 | MP0001270_distended_abdomen | 0.78637888 |
| 103 | MP0009840_abnormal_foam_cell | 0.78483739 |
| 104 | MP0003436_decreased_susceptibility_to | 0.77471384 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.76218628 |
| 106 | MP0009764_decreased_sensitivity_to | 0.75012797 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.74502940 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.74352893 |
| 109 | MP0005023_abnormal_wound_healing | 0.72290386 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.71742453 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.71167603 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.70783356 |
| 113 | MP0005388_respiratory_system_phenotype | 0.69572910 |
| 114 | MP0002133_abnormal_respiratory_system | 0.69572910 |
| 115 | MP0002160_abnormal_reproductive_system | 0.69435600 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.69073517 |
| 117 | MP0002928_abnormal_bile_duct | 0.68695514 |
| 118 | MP0002837_dystrophic_cardiac_calcinosis | 0.68525531 |
| 119 | MP0009115_abnormal_fat_cell | 0.67886135 |
| 120 | MP0008872_abnormal_physiological_respon | 0.67395673 |
| 121 | MP0009785_altered_susceptibility_to | 0.67385860 |
| 122 | MP0005166_decreased_susceptibility_to | 0.67033812 |
| 123 | MP0004043_abnormal_pH_regulation | 0.66219863 |
| 124 | MP0005508_abnormal_skeleton_morphology | 0.65573386 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.65421487 |
| 126 | MP0003115_abnormal_respiratory_system | 0.63788083 |
| 127 | MP0000343_altered_response_to | 0.63495052 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.62564968 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.62094589 |
| 130 | MP0003938_abnormal_ear_development | 0.61838204 |
| 131 | MP0004084_abnormal_cardiac_muscle | 0.61527789 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.60738035 |
| 133 | MP0003936_abnormal_reproductive_system | 0.59375962 |
| 134 | MP0004036_abnormal_muscle_relaxation | 0.59127766 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.57268158 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.57056825 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.55579727 |
| 138 | MP0005395_other_phenotype | 0.54881399 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.54775091 |
| 140 | MP0005334_abnormal_fat_pad | 0.53865526 |
| 141 | MP0000598_abnormal_liver_morphology | 0.53832847 |
| 142 | MP0000858_altered_metastatic_potential | 0.53618946 |
| 143 | MP0005376_homeostasis/metabolism_phenot | 0.53529834 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.51441098 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.51252834 |
| 146 | MP0004484_altered_response_of | 0.51176082 |
| 147 | MP0005025_abnormal_response_to | 0.47440005 |
| 148 | MP0000566_synostosis | 0.47078840 |
| 149 | MP0003953_abnormal_hormone_level | 0.45861075 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.45162335 |
| 151 | MP0005408_hypopigmentation | 0.42436444 |
| 152 | MP0006082_CNS_inflammation | 0.42111957 |
| 153 | MP0009763_increased_sensitivity_to | 0.40239798 |
| 154 | MP0001485_abnormal_pinna_reflex | 0.37784453 |
| 155 | MP0005501_abnormal_skin_physiology | 0.37679263 |
| 156 | MP0003303_peritoneal_inflammation | 0.36724408 |
| 157 | MP0008260_abnormal_autophagy | 0.35668092 |
| 158 | MP0002166_altered_tumor_susceptibility | 0.35249694 |
| 159 | MP0003724_increased_susceptibility_to | 0.35071392 |
| 160 | MP0001790_abnormal_immune_system | 0.33197029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.63281230 |
| 2 | Spondylolisthesis (HP:0003302) | 9.44063413 |
| 3 | Vascular tortuosity (HP:0004948) | 9.08018919 |
| 4 | Aortic dissection (HP:0002647) | 8.66472753 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 7.71645006 |
| 6 | Hydroxyprolinuria (HP:0003080) | 6.38700342 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 6.38700342 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.11230510 |
| 9 | Malnutrition (HP:0004395) | 5.01688427 |
| 10 | Aortic aneurysm (HP:0004942) | 4.93209036 |
| 11 | Fat malabsorption (HP:0002630) | 4.90991522 |
| 12 | Bicuspid aortic valve (HP:0001647) | 4.42362397 |
| 13 | Xanthomatosis (HP:0000991) | 4.40816932 |
| 14 | Neoplasm of the heart (HP:0100544) | 4.37276747 |
| 15 | Hyperglycinuria (HP:0003108) | 4.25213439 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.24842885 |
| 17 | Mitral valve prolapse (HP:0001634) | 4.17246096 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.12544576 |
| 19 | Ankle contracture (HP:0006466) | 4.09771418 |
| 20 | Abnormality of vitamin B metabolism (HP:0004340) | 3.99256594 |
| 21 | Chronic diarrhea (HP:0002028) | 3.99205393 |
| 22 | Acanthocytosis (HP:0001927) | 3.97956949 |
| 23 | Abnormality of vitamin metabolism (HP:0100508) | 3.90534784 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88379593 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.88379593 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.85182896 |
| 27 | Cerebral aneurysm (HP:0004944) | 3.80659298 |
| 28 | Hyperparathyroidism (HP:0000843) | 3.80427643 |
| 29 | Confusion (HP:0001289) | 3.76070395 |
| 30 | Abnormality of urine glucose concentration (HP:0011016) | 3.71033754 |
| 31 | Glycosuria (HP:0003076) | 3.71033754 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.69441566 |
| 33 | Premature rupture of membranes (HP:0001788) | 3.68482955 |
| 34 | Thyroid-stimulating hormone excess (HP:0002925) | 3.66474340 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.58404554 |
| 36 | Nausea (HP:0002018) | 3.54459749 |
| 37 | Steatorrhea (HP:0002570) | 3.49002897 |
| 38 | Proximal tubulopathy (HP:0000114) | 3.46261563 |
| 39 | Thin bony cortex (HP:0002753) | 3.34662213 |
| 40 | Ventricular fibrillation (HP:0001663) | 3.32528141 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31800590 |
| 42 | Pigmentary retinal degeneration (HP:0001146) | 3.31741750 |
| 43 | Gastrointestinal dysmotility (HP:0002579) | 3.29396454 |
| 44 | Hyperammonemia (HP:0001987) | 3.27984432 |
| 45 | Ulnar bowing (HP:0003031) | 3.26795375 |
| 46 | Type 1 muscle fiber predominance (HP:0003803) | 3.25491072 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.24182419 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 3.18895676 |
| 49 | Mesangial abnormality (HP:0001966) | 3.17611144 |
| 50 | Glomerulonephritis (HP:0000099) | 3.15414597 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 3.14887547 |
| 52 | Hemorrhage of the eye (HP:0011885) | 3.02592445 |
| 53 | Nephrolithiasis (HP:0000787) | 3.02174855 |
| 54 | Hyperlipoproteinemia (HP:0010980) | 3.00028068 |
| 55 | Complement deficiency (HP:0004431) | 2.98614265 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.94857665 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.94202485 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.93493310 |
| 59 | Hyperthyroidism (HP:0000836) | 2.93368641 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91756597 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90379056 |
| 62 | Alkalosis (HP:0001948) | 2.89901847 |
| 63 | Abdominal situs inversus (HP:0003363) | 2.88941272 |
| 64 | Abnormality of abdominal situs (HP:0011620) | 2.88941272 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.85998377 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85998377 |
| 67 | Wide cranial sutures (HP:0010537) | 2.85132208 |
| 68 | Right ventricular cardiomyopathy (HP:0011663) | 2.84891440 |
| 69 | Hypophosphatemia (HP:0002148) | 2.82984935 |
| 70 | Increased purine levels (HP:0004368) | 2.79613908 |
| 71 | Hyperuricemia (HP:0002149) | 2.79613908 |
| 72 | Potter facies (HP:0002009) | 2.78155799 |
| 73 | Facial shape deformation (HP:0011334) | 2.78155799 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.76502483 |
| 75 | Abnormal urine phosphate concentration (HP:0012599) | 2.74746661 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.73940029 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.71394186 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64665421 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64665421 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64665421 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.62093877 |
| 82 | Epidermoid cyst (HP:0200040) | 2.61813616 |
| 83 | Metabolic acidosis (HP:0001942) | 2.57575159 |
| 84 | Follicular hyperkeratosis (HP:0007502) | 2.57156950 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.54701511 |
| 86 | Arachnodactyly (HP:0001166) | 2.48504304 |
| 87 | Radial bowing (HP:0002986) | 2.44504043 |
| 88 | Protrusio acetabuli (HP:0003179) | 2.43240097 |
| 89 | Metabolic alkalosis (HP:0200114) | 2.43106720 |
| 90 | Fragile skin (HP:0001030) | 2.41696305 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 2.41039325 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.40146407 |
| 93 | Atrophic scars (HP:0001075) | 2.38570491 |
| 94 | Nephritis (HP:0000123) | 2.35278471 |
| 95 | Joint hemorrhage (HP:0005261) | 2.34001807 |
| 96 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32468374 |
| 97 | Cervical subluxation (HP:0003308) | 2.32280123 |
| 98 | Emphysema (HP:0002097) | 2.31630970 |
| 99 | Broad metatarsal (HP:0001783) | 2.30733069 |
| 100 | Spastic diplegia (HP:0001264) | 2.30154445 |
| 101 | Tarsal synostosis (HP:0008368) | 2.29896235 |
| 102 | Gout (HP:0001997) | 2.28053011 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.27994369 |
| 104 | Irritability (HP:0000737) | 2.25993310 |
| 105 | Rickets (HP:0002748) | 2.23261240 |
| 106 | Petechiae (HP:0000967) | 2.22596895 |
| 107 | Cerebral palsy (HP:0100021) | 2.20223788 |
| 108 | Aneurysm (HP:0002617) | 2.19389247 |
| 109 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18984456 |
| 110 | Poikilocytosis (HP:0004447) | 2.18649282 |
| 111 | Bowing of the arm (HP:0006488) | 2.18439035 |
| 112 | Bowed forearm bones (HP:0003956) | 2.18439035 |
| 113 | Focal segmental glomerulosclerosis (HP:0000097) | 2.17591557 |
| 114 | Purpura (HP:0000979) | 2.16017600 |
| 115 | Pancreatitis (HP:0001733) | 2.14897671 |
| 116 | Abnormality of complement system (HP:0005339) | 2.14856670 |
| 117 | Peritonitis (HP:0002586) | 2.13868219 |
| 118 | Hyporeflexia of lower limbs (HP:0002600) | 2.12548787 |
| 119 | Delayed CNS myelination (HP:0002188) | 2.12022972 |
| 120 | Slender build (HP:0001533) | 2.09988721 |
| 121 | Synostosis involving bones of the feet (HP:0009140) | 2.09662478 |
| 122 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.09662478 |
| 123 | Hyperglycinemia (HP:0002154) | 2.09125782 |
| 124 | Rectal prolapse (HP:0002035) | 2.09043279 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08744022 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 2.08744022 |
| 127 | Posterior subcapsular cataract (HP:0007787) | 2.07858992 |
| 128 | Hypotension (HP:0002615) | 2.06991348 |
| 129 | Ileus (HP:0002595) | 2.06808274 |
| 130 | Widely patent fontanelles and sutures (HP:0004492) | 2.05856134 |
| 131 | Tibial bowing (HP:0002982) | 2.05821944 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03445627 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 2.02218273 |
| 134 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01656269 |
| 135 | Vascular calcification (HP:0004934) | 2.00842658 |
| 136 | Arterial tortuosity (HP:0005116) | 10.1221501 |
| 137 | Femoral bowing (HP:0002980) | 1.96983227 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.95399221 |
| 139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95399221 |
| 140 | Syncope (HP:0001279) | 1.94225868 |
| 141 | Renal tubular acidosis (HP:0001947) | 1.92553564 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.92197762 |
| 143 | Testicular atrophy (HP:0000029) | 1.91834085 |
| 144 | Delayed epiphyseal ossification (HP:0002663) | 1.91713487 |
| 145 | Lethargy (HP:0001254) | 1.91196988 |
| 146 | Prolonged QT interval (HP:0001657) | 1.90761715 |
| 147 | Eczematoid dermatitis (HP:0000976) | 1.90433975 |
| 148 | Enlarged epiphyses (HP:0010580) | 1.90118909 |
| 149 | Villous atrophy (HP:0011473) | 1.89895019 |
| 150 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.89895019 |
| 151 | Spinal rigidity (HP:0003306) | 1.89771074 |
| 152 | Soft skin (HP:0000977) | 1.88879593 |
| 153 | Facial diplegia (HP:0001349) | 1.86785368 |
| 154 | Protuberant abdomen (HP:0001538) | 1.86680064 |
| 155 | Abnormality of serum amino acid levels (HP:0003112) | 1.85488138 |
| 156 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.85422763 |
| 157 | Increased connective tissue (HP:0009025) | 1.85212806 |
| 158 | Hypophosphatemic rickets (HP:0004912) | 1.83945846 |
| 159 | Elevated alkaline phosphatase (HP:0003155) | 1.83278641 |
| 160 | Elbow flexion contracture (HP:0002987) | 1.82656342 |
| 161 | Renal tubular dysfunction (HP:0000124) | 1.82471741 |
| 162 | Dilatation of the ascending aorta (HP:0005111) | 1.81292199 |
| 163 | Abdominal distention (HP:0003270) | 1.80125065 |
| 164 | Symptomatic seizures (HP:0011145) | 1.79558384 |
| 165 | Striae distensae (HP:0001065) | 1.79487308 |
| 166 | Hyperbilirubinemia (HP:0002904) | 1.78427243 |
| 167 | Abnormality of renin-angiotensin system (HP:0000847) | 1.77886515 |
| 168 | Osteomalacia (HP:0002749) | 1.77817299 |
| 169 | Hypercholesterolemia (HP:0003124) | 1.77099851 |
| 170 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.75558328 |
| 171 | Vomiting (HP:0002013) | 1.73389459 |
| 172 | Alopecia of scalp (HP:0002293) | 1.73288568 |
| 173 | Increased mean platelet volume (HP:0011877) | 1.70640638 |
| 174 | Polycythemia (HP:0001901) | 1.69990460 |
| 175 | Aplastic anemia (HP:0001915) | 1.66946419 |
| 176 | Absent frontal sinuses (HP:0002688) | 1.66912098 |
| 177 | Abnormal hemoglobin (HP:0011902) | 1.66774130 |
| 178 | Scapular winging (HP:0003691) | 1.64355263 |
| 179 | Autoimmune hemolytic anemia (HP:0001890) | 1.63371516 |
| 180 | Ulnar deviation of the wrist (HP:0003049) | 1.62707634 |
| 181 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.62478877 |
| 182 | Blue sclerae (HP:0000592) | 1.61859179 |
| 183 | Tetraparesis (HP:0002273) | 1.59449571 |
| 184 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.58918836 |
| 185 | Inguinal hernia (HP:0000023) | 1.58513332 |
| 186 | Abnormality of the costochondral junction (HP:0000919) | 1.58047938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.78600889 |
| 2 | MYLK | 5.38382632 |
| 3 | TGFBR2 | 4.01493895 |
| 4 | TTN | 3.87448142 |
| 5 | LMTK2 | 3.33654678 |
| 6 | TAOK3 | 3.06458723 |
| 7 | MST1R | 2.89531611 |
| 8 | ERN1 | 2.63596061 |
| 9 | MST4 | 2.52129875 |
| 10 | EPHB1 | 2.50148203 |
| 11 | MAPKAPK3 | 2.49181460 |
| 12 | PIK3CG | 2.38539854 |
| 13 | TESK2 | 2.33788529 |
| 14 | DMPK | 2.01203543 |
| 15 | PAK2 | 1.89759318 |
| 16 | PTK6 | 1.89388950 |
| 17 | EPHB2 | 1.85100895 |
| 18 | MET | 1.82517605 |
| 19 | TRIB3 | 1.72331045 |
| 20 | MAP3K12 | 1.71935208 |
| 21 | PTK2 | 1.71427005 |
| 22 | PDGFRA | 1.70060882 |
| 23 | STK39 | 1.69777823 |
| 24 | RIPK1 | 1.68825452 |
| 25 | PAK4 | 1.68035505 |
| 26 | FGFR2 | 1.62405924 |
| 27 | FER | 1.59575617 |
| 28 | TESK1 | 1.59378369 |
| 29 | MAP3K2 | 1.59040517 |
| 30 | PRKG2 | 1.52806655 |
| 31 | FRK | 1.47460458 |
| 32 | OXSR1 | 1.47289796 |
| 33 | LRRK2 | 1.47032688 |
| 34 | DDR2 | 1.42080307 |
| 35 | MAP4K1 | 1.32793639 |
| 36 | PTK2B | 1.23226810 |
| 37 | RPS6KB2 | 1.20521071 |
| 38 | PRPF4B | 1.15687264 |
| 39 | NME1 | 1.13865690 |
| 40 | TNIK | 1.11800256 |
| 41 | TIE1 | 1.11770305 |
| 42 | MAP3K10 | 1.09935519 |
| 43 | AKT3 | 1.09033690 |
| 44 | NTRK1 | 1.07392634 |
| 45 | LIMK1 | 1.05832253 |
| 46 | PAK3 | 1.05489651 |
| 47 | CDC42BPA | 1.04267770 |
| 48 | LATS1 | 1.01700501 |
| 49 | PAK1 | 1.00944630 |
| 50 | PRKACG | 0.98881525 |
| 51 | MAP3K11 | 0.97328998 |
| 52 | MAP3K7 | 0.95846462 |
| 53 | MAP3K1 | 0.95215811 |
| 54 | MAPK11 | 0.93479604 |
| 55 | PDK2 | 0.93316054 |
| 56 | EEF2K | 0.93181009 |
| 57 | STK38 | 0.92910338 |
| 58 | PKN2 | 0.91963186 |
| 59 | STK24 | 0.91124755 |
| 60 | EPHA3 | 0.87965575 |
| 61 | KSR2 | 0.85197565 |
| 62 | PRKAA2 | 0.83683170 |
| 63 | DYRK1B | 0.82742975 |
| 64 | JAK3 | 0.81877784 |
| 65 | RIPK4 | 0.79897230 |
| 66 | KDR | 0.79647837 |
| 67 | FGFR4 | 0.78712727 |
| 68 | PRKCZ | 0.78268862 |
| 69 | ROCK1 | 0.77763843 |
| 70 | DAPK3 | 0.72033207 |
| 71 | ABL2 | 0.70360834 |
| 72 | MAP2K6 | 0.69516987 |
| 73 | MAP2K2 | 0.67566129 |
| 74 | MAP3K3 | 0.67128502 |
| 75 | PDPK1 | 0.67105221 |
| 76 | ROCK2 | 0.66761070 |
| 77 | BMX | 0.63530582 |
| 78 | SRC | 0.62995799 |
| 79 | ILK | 0.62192633 |
| 80 | STK10 | 0.61380555 |
| 81 | PIM1 | 0.59435976 |
| 82 | TAOK1 | 0.58389472 |
| 83 | PRKD1 | 0.57669594 |
| 84 | CSF1R | 0.55022697 |
| 85 | JAK1 | 0.52114037 |
| 86 | TYK2 | 0.47690163 |
| 87 | PDGFRB | 0.46687198 |
| 88 | MUSK | 0.46652967 |
| 89 | MAP2K1 | 0.45947687 |
| 90 | RET | 0.45470768 |
| 91 | ZAP70 | 0.44829764 |
| 92 | GRK1 | 0.44574069 |
| 93 | RPS6KA2 | 0.43103610 |
| 94 | EPHA4 | 0.41826045 |
| 95 | GSK3A | 0.40332823 |
| 96 | JAK2 | 0.39576904 |
| 97 | PRKCI | 0.39516786 |
| 98 | IKBKE | 0.38362663 |
| 99 | CAMK2D | 0.38081893 |
| 100 | GRK6 | 0.37834676 |
| 101 | PRKCD | 0.37772562 |
| 102 | CDK6 | 0.36737026 |
| 103 | CASK | 0.36495681 |
| 104 | IRAK3 | 0.36465599 |
| 105 | TRPM7 | 0.35161615 |
| 106 | FYN | 0.34839597 |
| 107 | PDK1 | 0.34467459 |
| 108 | FGFR1 | 0.34324971 |
| 109 | IRAK1 | 0.33885031 |
| 110 | IGF1R | 0.33246184 |
| 111 | CAMK2G | 0.32995535 |
| 112 | ERBB2 | 0.32812141 |
| 113 | MAPKAPK2 | 0.32738599 |
| 114 | CAMK1 | 0.32513888 |
| 115 | TBK1 | 0.32374559 |
| 116 | PRKACA | 0.29974316 |
| 117 | BMPR2 | 0.29642339 |
| 118 | PIM2 | 0.28559244 |
| 119 | ICK | 0.28419249 |
| 120 | CSK | 0.28073057 |
| 121 | CAMKK1 | 0.27353044 |
| 122 | STK3 | 0.27045356 |
| 123 | CDK19 | 0.26796839 |
| 124 | MAPK4 | 0.26728790 |
| 125 | CAMK2B | 0.25820022 |
| 126 | NLK | 0.25768105 |
| 127 | ALK | 0.25709929 |
| 128 | DAPK2 | 0.25608196 |
| 129 | EPHA2 | 0.25465817 |
| 130 | SIK1 | 0.25308946 |
| 131 | ITK | 0.25088040 |
| 132 | FGFR3 | 0.25039709 |
| 133 | TYRO3 | 0.24709610 |
| 134 | SMG1 | 0.24156425 |
| 135 | MAP3K9 | 0.23844842 |
| 136 | MAP3K8 | 0.22476026 |
| 137 | SYK | 0.22427227 |
| 138 | AKT2 | 0.21650131 |
| 139 | ABL1 | 0.20711770 |
| 140 | LATS2 | 0.20567079 |
| 141 | PIK3CA | 0.19951695 |
| 142 | PRKCA | 0.19573321 |
| 143 | EGFR | 0.19493384 |
| 144 | PRKG1 | 0.19384776 |
| 145 | MATK | 0.19334378 |
| 146 | PRKCQ | 0.19133040 |
| 147 | LYN | 0.18139243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mineral absorption_Homo sapiens_hsa04978 | 2.76073978 |
| 2 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.66945626 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.57757235 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49915543 |
| 5 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.42398438 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.31109045 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.16098317 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.06853158 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.01137850 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00176269 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98973789 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.96223846 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96147295 |
| 14 | Amoebiasis_Homo sapiens_hsa05146 | 1.94766961 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93036049 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.91253725 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91000484 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.88505563 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.86428586 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.80291804 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.74404780 |
| 22 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.73059525 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.62419955 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62191762 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60530871 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55078562 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.54160654 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.52440351 |
| 29 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.51994885 |
| 30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51210694 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48054038 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43655306 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.42825088 |
| 34 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.40420242 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.36457923 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.35635932 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.34965513 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32993032 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31622778 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29611271 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.22588847 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.22212116 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21295899 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21149107 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19999660 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19252388 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19163339 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16458986 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.14744828 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14265072 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13298313 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12435728 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.12402334 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11228337 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10752506 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10207818 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09453671 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08158600 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06334161 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02406094 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01987227 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.97372470 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96292176 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94002161 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.92475473 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92444320 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91441454 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90587488 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88932238 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88906464 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85216589 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83531284 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80517652 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77647065 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77456082 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.76285397 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75615082 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75365880 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73915923 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73190689 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70272017 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69883132 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69417848 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68487687 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67734838 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.67635280 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66373549 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65753262 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.64859039 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64733395 |
| 91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63836250 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.63138280 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.63104609 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62981479 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61481541 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.61149886 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.58425099 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57811182 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56326197 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55492531 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55440314 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55106395 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54652250 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53771197 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51132444 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49793179 |
| 107 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49369497 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.49353117 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48848809 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48807417 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46949591 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45366432 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44541478 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43861432 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43473391 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43365111 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43303883 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42201199 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41747310 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41194717 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40003867 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39396826 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.35418829 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35187025 |
| 125 | Allograft rejection_Homo sapiens_hsa05330 | 0.34042548 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33617122 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33222085 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32772792 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31420105 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30573107 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29895136 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28477196 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28264061 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.27967669 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.27780365 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26794081 |
| 137 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26137778 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24551941 |
| 139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22525159 |
| 140 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21577713 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20793301 |
| 142 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16714490 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.14653949 |
| 144 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.13163727 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12938498 |
| 146 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01720308 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.00201637 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0419190 |
| 149 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0338050 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0069043 |
| 151 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0015217 |
| 152 | Hepatitis C_Homo sapiens_hsa05160 | -0.0001069 |

